Reviews5 May 2015
A Systematic Review
    Author, Article, and Disclosure Information



    The role of fecal microbiota transplantation (FMT) for Clostridium difficile infection (CDI) is not well-known.


    To assess the efficacy, comparative effectiveness, and harms of FMT for CDI.

    Data Sources:

    MEDLINE (1980 to January 2015), Cochrane Library, and, followed by hand-searching references from systematic reviews and identified studies.

    Study Selection:

    Any study of FMT to treat adult patients with CDI; case reports were only used to report harms.

    Data Extraction:

    Data were extracted by 1 author and verified by another; 2 authors independently assessed risk of bias and strength of evidence.

    Data Synthesis:

    Two randomized, controlled trials (RCTs); 28 case-series studies; and 5 case reports were included. Two RCTs and 21 case-series studies (516 patients receiving FMT) reported using FMT for patients with recurrent CDI. A high proportion of treated patients had symptom resolution; however, the role of previous antimicrobials is unclear. One RCT comparing FMT with 2 control groups (n = 43) reported resolution of symptoms in 81%, 31%, and 23% of the FMT, vancomycin, or vancomycin-plus-bowel lavage groups, respectively (P < 0.001 for both control groups vs. FMT). An RCT comparing FMT route (n = 20) reported no difference between groups (60% in the nasogastric tube group and 80% in the colonoscopy group; P = 0.63). Across all studies for recurrent CDI, symptom resolution was seen in 85% of cases. In 7 case-series studies of patients with refractory CDI, symptom resolution ranged from 0% to 100%. Among 7 patients treated with FMT for initial CDI, results were mixed.


    Most studies were uncontrolled case-series studies; only 2 RCTs were available for analysis.


    Fecal microbiota transplantation may have a substantial effect with few short-term adverse events for recurrent CDI. Evidence is insufficient on FMT for refractory or initial CDI treatment and on whether effects vary by donor, preparation, or delivery method.

    Primary Funding Source:

    U.S. Department of Veterans Affairs.


    • 1. Bartlett JGChang TWGurwith MGorbach SLOnderdonk ABAntibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med1978;298:531-4. [PMID: 625309] CrossrefMedlineGoogle Scholar
    • 2. Larson HEPrice ABHonour PBorriello SP Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet1978;1:1063-6. [PMID: 77366] CrossrefMedlineGoogle Scholar
    • 3. Kuntz JLChrischilles EAPendergast JFHerwaldt LAPolgreen PMIncidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study. BMC Infect Dis2011;11:194. [PMID: 21762504] doi:10.1186/1471-2334-11-194 CrossrefMedlineGoogle Scholar
    • 4. Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2013. Accessed at on 8 May 2014. Google Scholar
    • 5. Johnson SRecurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect2009;58:403-10. [PMID: 19394704] doi:10.1016/j.jinf.2009.03.010 CrossrefMedlineGoogle Scholar
    • 6. Louie TJMiller MAMullane KMWeiss KLentnek AGolan Yet alOPT-80-003 Clinical Study GroupFidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med2011;364:422-31. [PMID: 21288078] doi:10.1056/NEJMoa0910812 CrossrefMedlineGoogle Scholar
    • 7. Surawicz CMMcFarland LVGreenberg RNRubin MFekety RMulligan MEet alThe search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis2000;31:1012-7. [PMID: 11049785] CrossrefMedlineGoogle Scholar
    • 8. McFarland LVElmer GWSurawicz CMBreaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol2002;97:1769-75. [PMID: 12135033] CrossrefMedlineGoogle Scholar
    • 9. Wilson KHThe microecology of Clostridium difficile. Clin Infect Dis1993;16 Suppl 4:S214-8. [PMID: 8324122] CrossrefMedlineGoogle Scholar
    • 10. Cammarota GIaniro GGasbarrini AFecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol2014;48:693-702. [PMID: 24440934] doi:10.1097/MCG.0000000000000046 CrossrefMedlineGoogle Scholar
    • 11. van Nood EVrieze ANieuwdorp MFuentes SZoetendal EGde Vos WMet alDuodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med2013;368:407-15. [PMID: 23323867] doi:10.1056/NEJMoa1205037 CrossrefMedlineGoogle Scholar
    • 12. Silverman MSDavis IPillai DRSuccess of self-administered home fecal transplantation for chronic Clostridium difficile infection. Clin Gastroenterol Hepatol2010;8:471-3. [PMID: 20117243] doi:10.1016/j.cgh.2010.01.007 CrossrefMedlineGoogle Scholar
    • 13. Debast SBBauer MPKuijper EJEuropean Society of Clinical Microbiology and Infectious DiseasesEuropean Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect2014;20 Suppl 2:1-26. [PMID: 24118601] doi:10.1111/1469-0691.12418 CrossrefMedlineGoogle Scholar
    • 14. Surawicz CMBrandt LJBinion DGAnanthakrishnan ANCurry SRGilligan PHet alGuidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol2013;108:478-98. [PMID: 23439232] doi:10.1038/ajg.2013.4 CrossrefMedlineGoogle Scholar
    • 15. Bakken JSBorody TBrandt LJBrill JVDemarco DCFranzos MAet alFecal Microbiota Transplantation WorkgroupTreating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol2011;9:1044-9. [PMID: 21871249] doi:10.1016/j.cgh.2011.08.014 CrossrefMedlineGoogle Scholar
    • 16. Owens DKLohr KNAtkins DTreadwell JRReston JTBass EBet alAHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions—Agency for Healthcare Research and Quality and the Effective Health-Care Program. J Clin Epidemiol2010;63:513-23. [PMID: 19595577] doi:10.1016/j.jclinepi.2009.03.009 CrossrefMedlineGoogle Scholar
    • 17. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. Accessed at on 6 October 2014. Google Scholar
    • 18. Youngster ISauk JPindar CWilson RGKaplan JLSmith MBet alFecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis2014;58:1515-22. [PMID: 24762631] doi:10.1093/cid/ciu135 CrossrefMedlineGoogle Scholar
    • 19. Youngster IRussell GHPindar CZiv-Baran TSauk JHohmann ELOral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA2014;312:1772-8. [PMID: 25322359] doi:10.1001/jama.2014.13875 CrossrefMedlineGoogle Scholar
    • 20. Yoon SSBrandt LJTreatment of refractory/recurrent C. difficile–associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients. J Clin Gastroenterol2010;44:562-6. [PMID: 20463588] doi:10.1097/MCG.0b013e3181dac035 CrossrefMedlineGoogle Scholar
    • 21. Tvede MRask-Madsen JBacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet1989;1:1156-60. [PMID: 2566734] CrossrefMedlineGoogle Scholar
    • 22. Rubin TAGessert CEAas JBakken JSFecal microbiome transplantation for recurrent Clostridium difficile infection: report on a case series. Anaerobe2013;19:22-6. [PMID: 23182843] doi:10.1016/j.anaerobe.2012.11.004 CrossrefMedlineGoogle Scholar
    • 23. Rohlke FSurawicz CMStollman NFecal flora reconstitution for recurrent Clostridium difficile infection: results and methodology. J Clin Gastroenterol2010;44:567-70. [PMID: 20485184] doi:10.1097/MCG.0b013e3181dadb10 CrossrefMedlineGoogle Scholar
    • 24. Pathak REnuh HAPatel AWickremesinghe PTreatment of relapsing Clostridium difficile infection using fecal microbiota transplantation. Clin Exp Gastroenterol2013;7:1-6. [PMID: 24421645] doi:10.2147/CEG.S53410 CrossrefMedlineGoogle Scholar
    • 25. Paterson DLIredell JWhitby MPutting back the bugs: bacterial treatment relieves chronic diarrhoea [Letter]. Med J Aust1994;160:232-3. [PMID: 8309401] CrossrefMedlineGoogle Scholar
    • 26. Patel NCGriesbach CLDiBaise JKOrenstein RFecal microbiota transplant for recurrent Clostridium difficile infection: Mayo Clinic in Arizona experience. Mayo Clin Proc2013;88:799-805. [PMID: 23910407] doi:10.1016/j.mayocp.2013.04.022 CrossrefMedlineGoogle Scholar
    • 27. Mellow MHKanatzar AColonoscopic fecal bacteriotherapy in the treatment of recurrent Clostridium difficile infection—results and follow-up. J Okla State Med Assoc2011;104:89-91. [PMID: 21608450] MedlineGoogle Scholar
    • 28. Mattila EUusitalo-Seppl RWuorela MLehtola LNurmi HRistikankare Met alFecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology2012;142:490-6. [PMID: 22155369] doi:10.1053/j.gastro.2011.11.037 CrossrefMedlineGoogle Scholar
    • 29. MacConnachie AAFox RKennedy DRSeaton RAFaecal transplant for recurrent Clostridium difficile–associated diarrhoea: a UK case series. QJM2009;102:781-4. [PMID: 19726581] doi:10.1093/qjmed/hcp118 CrossrefMedlineGoogle Scholar
    • 30. Khan MASofi AAAhmad UAlaradi OKhan ARHammad Tet alEfficacy and safety of, and patient satisfaction with, colonoscopic-administered fecal microbiota transplantation in relapsing and refractory community- and hospital-acquired Clostridium difficile infection. Can J Gastroenterol Hepatol2014;28:434-8. [PMID: 25014180] CrossrefMedlineGoogle Scholar
    • 31. Kelly CRde Leon LJasutkar NFecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results. J Clin Gastroenterol2012;46:145-9. [PMID: 22157239] doi:10.1097/MCG.0b013e318234570b CrossrefMedlineGoogle Scholar
    • 32. Hamilton MJWeingarden ARSadowsky MJKhoruts AStandardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol2012;107:761-7. [PMID: 22290405] doi:10.1038/ajg.2011.482 CrossrefMedlineGoogle Scholar
    • 33. Gustafsson ABerstad ALund-T nnesen SMidtvedt TNorin EThe effect of faecal enema on five microflora-associated characteristics in patients with antibiotic-associated diarrhoea. Scand J Gastroenterol1999;34:580-6. [PMID: 10440607] CrossrefMedlineGoogle Scholar
    • 34. Garborg KWaagsb BStallemo AMatre JSundy AResults of faecal donor instillation therapy for recurrent Clostridium difficile–associated diarrhoea. Scand J Infect Dis2010;42:857-61. [PMID: 20662620] doi:10.3109/00365548.2010.499541 CrossrefMedlineGoogle Scholar
    • 35. Emanuelsson FClaesson BELjungstrm LTvede MUng KAFaecal microbiota transplantation and bacteriotherapy for recurrent Clostridium difficile infection: a retrospective evaluation of 31 patients. Scand J Infect Dis2014;46:89-97. [PMID: 24354958] doi:10.3109/00365548.2013.858181 CrossrefMedlineGoogle Scholar
    • 36. Dutta SKGirotra MGarg SDutta Avon Rosenvinge ECMaddox Cet alEfficacy of combined jejunal and colonic fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol2014;12:1572-6. [PMID: 24440222] doi:10.1016/j.cgh.2013.12.032 CrossrefMedlineGoogle Scholar
    • 37. Cammarota GIaniro GGasbarrini AMasucci LSanguinetti MFaecal transplantation for Clostridium difficile infection. Three cases treated in Italy [Letter]. Dig Liver Dis2014;46:475. [PMID: 24457126] doi:10.1016/j.dld.2013.12.011 CrossrefMedlineGoogle Scholar
    • 38. Aas JGessert CEBakken JSRecurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis2003;36:580-5. [PMID: 12594638] CrossrefMedlineGoogle Scholar
    • 39. Lee CHBelanger JEKassam ZSmieja MHiggins DBroukhanski Get alThe outcome and long-term follow-up of 94 patients with recurrent and refractory Clostridium difficile infection using single to multiple fecal microbiota transplantation via retention enema. Eur J Clin Microbiol Infect Dis2014;33:1425-8. [PMID: 24627239] doi:10.1007/s10096-014-2088-9 CrossrefMedlineGoogle Scholar
    • 40. Zainah HHassan MShiekh-Sroujieh LHassan SAlangaden GRamesh MIntestinal microbiota transplantation, a simple and effective treatment for severe and refractory Clostridium difficile infection. Dig Dis Sci2015;60:181-5. [PMID: 25052150] doi:10.1007/s10620-014-3296-y CrossrefMedlineGoogle Scholar
    • 41. Weingarden ARHamilton MJSadowsky MJKhoruts AResolution of severe Clostridium difficile infection following sequential fecal microbiota transplantation [Letter]. J Clin Gastroenterol2013;47:735-7. [PMID: 23632358] doi:10.1097/MCG.0b013e31829004ae CrossrefMedlineGoogle Scholar
    • 42. Bowden TAMansberger ARLykins LEPseudomembraneous enterocolitis: mechanism for restoring floral homeostasis. Am Surg1981;47:178-83. [PMID: 7224366] MedlineGoogle Scholar
    • 43. Eiseman BSilen WBascom GSKauvar AJFecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery1958;44:854-9. [PMID: 13592638] MedlineGoogle Scholar
    • 44. Kelly CRIhunnah CFischer MKhoruts ASurawicz CAfzali Aet alFecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol2014;109:1065-71. [PMID: 24890442] doi:10.1038/ajg.2014.133 CrossrefMedlineGoogle Scholar
    • 45. Solari PRFairchild PGNoa LJWallace MRTempered enthusiasm for fecal transplant [Letter]. Clin Infect Dis2014;59:319. [PMID: 24759832] doi:10.1093/cid/ciu278 CrossrefMedlineGoogle Scholar
    • 46. Kleger ASchnell JEssig AWagner MBommer MSeufferlein Tet alFecal transplant in refractory Clostridium difficile colitis. Dtsch Arztebl Int2013;110:108-15. [PMID: 23468820] doi:10.3238/arztebl.2013.0108 CrossrefMedlineGoogle Scholar
    • 47. Quera REspinoza REstay CRivera DBacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection [Letter]. J Crohns Colitis2014;8:252-3. [PMID: 24184170] doi:10.1016/j.crohns.2013.10.002 CrossrefMedlineGoogle Scholar
    • 48. De Leon LMWatson JBKelly CRTransient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol2013;11:1036-8. [PMID: 23669309] doi:10.1016/j.cgh.2013.04.045 CrossrefMedlineGoogle Scholar
    • 49. Schwartz MGluck MKoon SNorovirus gastroenteritis after fecal microbiota transplantation for treatment of Clostridium difficile infection despite asymptomatic donors and lack of sick contacts [Letter]. Am J Gastroenterol2013;108:1367. [PMID: 23912408] doi:10.1038/ajg.2013.164 CrossrefMedlineGoogle Scholar
    • 50. Brandt LJAroniadis OCMellow MKanatzar AKelly CPark Tet alLong-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol2012;107:1079-87. [PMID: 22450732] doi:10.1038/ajg.2012.60 CrossrefMedlineGoogle Scholar
    • 51. Johnson SSchriever CGalang MKelly CPGerding DNInterruption of recurrent Clostridium difficile–associated diarrhea episodes by serial therapy with vancomycin and rifaximin. Clin Infect Dis2007;44:846-8. [PMID: 17304459] CrossrefMedlineGoogle Scholar
    • 52. Tedesco FJGordon DFortson WCApproach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis. Am J Gastroenterol1985;80:867-8. [PMID: 4050760] MedlineGoogle Scholar
    • 53. Moore TARodriguez ABakken JSReply to Solari et al [Letter]. Clin Infect Dis2014;59:319-20. [PMID: 24759828] doi:10.1093/cid/ciu279 CrossrefMedlineGoogle Scholar
    • 54. Lund-T nnesen SBerstad ASchreiner AMidtvedt T[Clostridium difficile–associated diarrhea treated with homologous feces]. Tidsskr Nor Laegeforen1998;118:1027-30. [PMID: 9531822] MedlineGoogle Scholar
    • 55. Nieuwdorp Mvan Nood ESpeelman Pvan Heukelem HAJansen JMVisser CEet al[Treatment of recurrent Clostridium difficile–associated diarrhoea with a suspension of donor faeces]. Ned Tijdschr Geneeskd2008;152:1927-32. [PMID: 18808083] MedlineGoogle Scholar
    • 56. Pol k PFreibergerov MJurnkov JKocourkov HMikešov LSvacina Ret al[First experiences with faecal bacteriotherapy in the treatment of relapsing pseudomembranous colitis due to Clostridium difficile]. Klin Mikrobiol Infekc Lek2011;17:214-7. [PMID: 22247032] MedlineGoogle Scholar
    • 57. Sihvonen RPaavola MMalmivaara AIt l AJoukainen ANurmi Het alFinnish Degenerative Meniscal Lesion Study (FIDELITY) GroupArthroscopic partial meniscectomy versus sham surgery for a degenerative meniscal tear. N Engl J Med2013;369:2515-24. [PMID: 24369076] doi:10.1056/NEJMoa1305189 CrossrefMedlineGoogle Scholar
    • 58. Bhatt DLKandzari DEO'Neill WWD'Agostino RFlack JMKatzen BTet alSYMPLICITY HTN-3 InvestigatorsA controlled trial of renal denervation for resistant hypertension. N Engl J Med2014;370:1393-401. [PMID: 24678939] doi:10.1056/NEJMoa1402670 CrossrefMedlineGoogle Scholar
    • 59. Redberg RFSham controls in medical device trials. N Engl J Med2014;371:892-3. [PMID: 25184861] doi:10.1056/NEJMp1406388 CrossrefMedlineGoogle Scholar